Paper39769050
Damage of the Bone Marrow Stromal Precursors in Patients with Acute Leukemia at the Onset of the Disease and During Treatment.
Sadovskaya A and 13 others. Int J Mol Sci, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Damage of the Bone Marrow Stromal Precursors in Patients with Acute Leukemia at the Onset of the Disease and During Treatment. Papers, record 39769050. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39769050
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Damage of the Bone Marrow Stromal Precursors in Patients with Acute Leukemia at the Onset of the Disease and During Treatment.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mesenchymal Stem Cells | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Humans | |
| Male | |
| Adult | |
| Female | |
| Middle Aged | |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | |
| Bone Marrow Cells | |
| Aged | |
| Proteome | |
| Cell Proliferation | |
| Adolescent | |
| Young Adult |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 22-15-00018 | Russian Science Foundation | PubMed |
Source PubMed
References67
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22242033 | Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease-A Phase II Study. | Stem Cells Int | 2012 | https://conductscience.org/library/papers/22242033 | PubMed |
| 2 | 28679949 | AML-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growth. | JCI Insight | 2017 | https://conductscience.org/library/papers/28679949 | PubMed |
| 3 | 31130381 | A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia. | Cell | 2019 | https://conductscience.org/library/papers/31130381 | PubMed |
| 4 | 31139016 | Ally to adversary: mesenchymal stem cells and their transformation in leukaemia. | Cancer Cell Int | 2019 | https://conductscience.org/library/papers/31139016 | PubMed |
| 5 | 35378291 | Characterization of the Secretome, Transcriptome, and Proteome of Human β Cell Line EndoC-βH1. | Mol Cell Proteomics | 2022 | https://conductscience.org/library/papers/35378291 | PubMed |
| 6 | 23149415 | Enhanced Angpt1/Tie2 signaling affects the differentiation and long-term repopulation ability of hematopoietic stem cells. | Biochem Biophys Res Commun | 2013 | https://conductscience.org/library/papers/23149415 | PubMed |
| 7 | 33922612 | The Bone Marrow Niche in B-Cell Acute Lymphoblastic Leukemia: The Role of Microenvironment from Pre-Leukemia to Overt Leukemia. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33922612 | PubMed |
| 8 | 28764769 | Anabolic role of lysyl oxidase like-2 in cartilage of knee and temporomandibular joints with osteoarthritis. | Arthritis Res Ther | 2017 | https://conductscience.org/library/papers/28764769 | PubMed |
| 9 | 28235783 | Proteome and Secretome Analysis Reveals Differential Post-transcriptional Regulation of Toll-like Receptor Responses. | Mol Cell Proteomics | 2017 | https://conductscience.org/library/papers/28235783 | PubMed |
| 10 | 30726736 | Bone Marrow Mesenchymal Stromal Cell-Derived Periostin Promotes B-ALL Progression by Modulating CCL2 in Leukemia Cells. | Cell Rep | 2019 | https://conductscience.org/library/papers/30726736 | PubMed |
| 11 | 37240298 | Acute Myeloid Leukemia Causes Serious and Partially Irreversible Changes in Secretomes of Bone Marrow Multipotent Mesenchymal Stromal Cells. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37240298 | PubMed |
| 12 | 24823376 | Vasculature-associated cells expressing nestin in developing bones encompass early cells in the osteoblast and endothelial lineage. | Dev Cell | 2014 | https://conductscience.org/library/papers/24823376 | PubMed |
| 13 | 33561425 | Endothelium-derived stromal cells contribute to hematopoietic bone marrow niche formation. | Cell Stem Cell | 2021 | https://conductscience.org/library/papers/33561425 | PubMed |
| 14 | 32872365 | Wnt Signaling in Leukemia and Its Bone Marrow Microenvironment. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32872365 | PubMed |
| 15 | 26279521 | The molecular signature of AML mesenchymal stromal cells reveals candidate genes related to the leukemogenic process. | Cancer Lett | 2015 | https://conductscience.org/library/papers/26279521 | PubMed |
| 16 | 30671226 | Hematopoiesis and microenvironment in hematological malignancies. | Cell Regen | 2018 | https://conductscience.org/library/papers/30671226 | PubMed |
| 17 | 35183534 | The contributory roles of the CXCL12/CXCR4/CXCR7 axis in normal and malignant hematopoiesis: A possible therapeutic target in hematologic malignancies. | Eur J Pharmacol | 2022 | https://conductscience.org/library/papers/35183534 | PubMed |
| 18 | 36180072 | OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases. | J Immunother Cancer | 2022 | https://conductscience.org/library/papers/36180072 | PubMed |
| 19 | 35508166 | Colony stimulating factor-1 producing endothelial cells and mesenchymal stromal cells maintain monocytes within a perivascular bone marrow niche. | Immunity | 2022 | https://conductscience.org/library/papers/35508166 | PubMed |
| 20 | 36697954 | FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis. | Ann Hematol | 2023 | https://conductscience.org/library/papers/36697954 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42653405 | The Proteome of Bone Marrow Multipotent Mesenchymal Stromal Cells Undergoes Significant Alterations in Acute Leukemia Patients at the Onset and During Treatment. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653405 | PubMed |
| 40427092 | Blood Serum from Patients with Acute Leukemia Inhibits the Growth of Bone Marrow Multipotent Mesenchymal Stromal Cells. | Biomedicines | 2025 | https://conductscience.org/library/papers/40427092 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39769050
GET https://conductscience.org/api/papers/v1/39769050/references?page=2